Urovant Sciences Ltd (UROV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | UROV | AMGN | VRTX | GILD | BMY |
| Company | Urovant Sciences Ltd | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 16.23 | 262.18 | 403.14 | 92.62 | 56.93 |
| High | 16.24 | 263.58 | 409.60 | 92.83 | 57.38 |
| Low | 16.21 | 258.31 | 402.72 | 91.40 | 56.52 |
| Last | 16.24 | 259.28 | 405.76 | 91.88 | 56.79 |
| Change | +0.01 | -1.36 | +3.06 | -0.49 | +0.23 |
| % Change | +0.06% | -0.52% | +0.76% | -0.53% | +0.41% |
| Volume | 1,739,000 | 2,357,900 | 1,277,800 | 3,496,000 | 9,093,600 |
| 20-Day Average Volume | 143,510 | 3,757,990 | 1,887,665 | 6,799,140 | 11,264,160 |
| Previous Close | 16.23 | 260.64 | 402.70 | 92.37 | 56.56 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 16.21 | 267.30 | 437.24 | 92.40 | 57.33 |
| 20-Day Raw Stochastic | 87.10% | 22.40% | 28.30% | 49.64% | 37.08% |
| 20-Day Relative Strength | 65.56% | 31.41% | 35.42% | 51.41% | 50.12% |
| Weighted Alpha | +6.45 | -19.55 | -9.93 | +19.58 | +16.07 |
| Today's Opinion | 100% Buy | 88% Sell | 72% Sell | 88% Buy | 72% Buy |
| Previous Opinion | 100% Buy | 88% Sell | 72% Sell | 88% Buy | 56% Buy |
| Last Month's Opinion | 96% Buy | 72% Sell | 8% Sell | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 03/19/21 | -1.97% since 12/24/24 | -0.59% since 12/24/24 | -2.20% since 12/24/24 | -1.68% since 12/24/24 |
| Low | 16.20 on 03/24/21 | 258.31 on 01/02/25 | 399.06 on 12/30/24 | 91.40 on 01/02/25 | 55.93 on 12/31/24 |
| High | 16.25 on 03/25/21 | 264.73 on 12/26/24 | 411.29 on 12/26/24 | 94.55 on 12/26/24 | 58.38 on 12/27/24 |
| 1-Month | |||||
| %Chg | +0.43% since 02/26/21 | -6.77% since 12/02/24 | -12.88% since 12/02/24 | -2.28% since 12/02/24 | -5.26% since 12/02/24 |
| Low | 16.10 on 03/02/21 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 89.15 on 12/13/24 | 55.04 on 12/13/24 |
| High | 16.26 on 03/19/21 | 281.38 on 12/03/24 | 476.46 on 12/10/24 | 94.65 on 12/11/24 | 60.09 on 12/03/24 |
| 3-Month | |||||
| %Chg | +1.25% since 12/24/20 | -18.91% since 10/02/24 | -12.20% since 10/02/24 | +8.43% since 10/02/24 | +5.64% since 10/02/24 |
| Low | 16.03 on 12/30/20 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 83.98 on 10/04/24 | 51.31 on 10/15/24 |
| High | 16.26 on 03/19/21 | 329.17 on 10/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| 6-Month | |||||
| %Chg | +76.14% since 09/25/20 | -16.57% since 07/02/24 | -14.36% since 07/02/24 | +34.33% since 07/02/24 | +40.40% since 07/02/24 |
| Low | 7.15 on 11/02/20 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 66.01 on 07/05/24 | 39.35 on 07/05/24 |
| High | 16.26 on 03/19/21 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 531,746 | 140,102,608 | 103,706,928 | 115,117,592 | 114,713,688 |
| Shares Outstanding, K | 32,743 | 537,533 | 257,529 | 1,246,266 | 2,028,177 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | -146,750,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 2,771,900,000 | 7,545,000,000 | 11,892,000,000 |
| Last Quarter Net Income | -46,800,000 | 2,830,000,000 | 1,045,400,000 | 1,253,000,000 | 1,211,000,000 |
| 60-Month Beta | 2.35 | 0.55 | 0.36 | 0.18 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 | 1.80 on 10/31/24 |
| Latest Earnings Date | 02/11/21 | 02/04/25 | 02/03/25 | 02/11/25 | 02/06/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.770 on 12/13/24 | 0.620 on 01/03/25 |
| Next Ex-Dividends Date | N/A | 02/14/25 | N/A | 12/13/24 | 01/03/25 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.49 | 0.00 | 20.77 | 47.91 |